EPISODE · Aug 7, 2024 · 24 MIN
Creating A Drug Delivery ARMMs Race
from The Bio Report · host Levine Media Group
While there have been a parade of novel therapeutic modalities in recent years, many of them are constrained by delivery challenges. Vesigen Therapeutics is developing novel drug delivery technology known as ARMMs that can transport a wide range of therapeutic payloads directly into the cytoplasm of target cells. We spoke to Paulash Mohsen, CEO of Vesigen, about the company’s delivery technology, its advantages over viral vectors and liquid nanoparticles, and how it enables the targeting of previously undruggable targets.
What this episode covers
Paulash Mohsen, CEO of Vesigen Therapeutics, discusses the company’s delivery technology, its advantages over viral vectors and liquid nanoparticles, and how they enable the targeting of previously undruggable targets.
NOW PLAYING
Creating A Drug Delivery ARMMs Race
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m